Oncolytics Biotech Inc.: Oncolytics Biotech Announces Voting

Mr. Parsons served as the Chief Financial Officer of Trillium Therapeutics, which was recently acquired by Pfizer Inc. SAN DIEGO and CALGARY, AB, June 17, 2022 /PRNewswire/ -- Oncolytics

Related Keywords

Canada , Canadian , Wayne Pisano , Matthewc Coffey , Berndr Seizinger , Timothy Mccarthy , Angela Holtham , Matt Coffey , Jon Patton , Jamest Parsons , Deborahm Brown , Oncolytics Biotech Inc , Amorfix Life Sciences Ltd , Company Contact , Trillium Therapeutics Inc , Aptose Biosciences Inc , Nasdaq , Diamedica Therapeutics Inc , Pfizer Inc , Securities Exchange , Audit Committees Of Sernova Corp , Chief Financial Officer , Trillium Therapeutics , Annual General Meeting , Oncolytics Biotech Board , Chief Executive Officer , Annual Meeting , Vice President , Aptose Biosciences , Lorus Therapeutics , Audit Committees , Diamedica Therapeutics , Securities Exchange Act , Oncolytics , Biotech , Nnounces , Voting , Results , Rom , Nnual , Eneral , Meeting , Shareholders , Ppoints , Games , Arsons , Board , Directors ,